Loading...
•
Jun 30, 2022
Medifast Q2 2022 Earnings Report
Medifast reported solid results in Q2 2022, with revenue increasing by 15% and active earning OPTAVIA Coaches growing by almost 15%.
Key Takeaways
Medifast's Q2 2022 revenue increased by 15.0% to $453.3 million, driven by a 14.9% increase in active earning OPTAVIA Coaches to 68,000. Revenue per coach slightly increased. Net income decreased by 16.7% to $39.1 million, and EPS decreased by 13.6% to $3.42. The company has updated its full-year 2022 revenue guidance to $1.58 billion to $1.66 billion.
Revenue increased by 15.0% to $453.3 million.
The number of independent active earning OPTAVIA Coaches grew by 14.9% to 68,000.
Revenue per active earning OPTAVIA Coach was $6,667, a slight increase above the prior year.
Net income decreased by 16.7% to $39.1 million.
Forward Guidance
The Company expects full-year 2022 revenue to be in the range of $1.58 billion to $1.66 billion and full-year 2022 non-GAAP diluted EPS to be in the range of $12.70 to $14.10.
Challenges Ahead
- Macroeconomic factors such as inflation have impacted customer retention.
- Consumer sentiment has impacted customer retention.
- The decline in the Company’s outlook is due to macroeconomic factors.
- The revised full-year 2022 earnings guidance assumes a 24.25% to 25.25% effective tax rate.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...